Sign up to be notified when SLU-PP-332 is available and receive early access to this breakthrough therapy
Niu G, Wang G, Lau J, Lang L, Jacobson O, Ma Y, Kiesewetter DO, Zhang S, Chen X
Patients with obesity who have type 1 diabetes are suboptimally treated for their obesity because doctors were unclear how effective the medications would be for obesity and because there were concerns regarding the risks pertaining to their type 1 diabetes, Ebaa Al Ozairi , MD, chief medical officer and head of clinical research and clinical trials at Dasman Diabetes Institute in Kuwait, and Carel le Roux, MD, PhD , professor at Ulster University School of Medicine in the U.K., told Healio
Lipo cannot fix this bulge because its not made up of fat
Although currently FDA-approved for diabetes and weight management, clinical evidence indicates these medications also interact with the brains neurological reward pathways involved in substance use disorder